Novo Nordisk’s Wegovy weight loss drug wins UK approval for use as a heart treatment

[ad_1] Novo Nordisk’s Wegovy weight loss drug has seen a meteoric rise in popularity.  Nurphoto |…

Healthy Returns: Diabetes drug Ozempic may lower dementia risk, nicotine use

[ad_1] A box of Ozempic made by Novo Nordisk is seen at a pharmacy in London,…

Healthy Returns: Drugmakers are racing to develop more convenient weight loss pills

[ad_1] Aykut Karahan | Istock | Getty Images Think a friend or colleague should be getting…

Pfizer moves forward with once-daily version of weight loss pill after setbacks

[ad_1] Sopa Images | Lightrocket | Getty Images Pfizer on Thursday said it will move forward…

Federal Trade Commission to sue drug middlemen over prices of medications including insulin, source says

[ad_1] Federal Trade Commission Chair Lina Khan testifies during a hearing of the House Appropriations Subcommittee…

Novo Nordisk shares shrug off concerns over study linking weight loss drugs to rare eye condition

[ad_1] A box of Ozempic and contents sit on a table in Dudley, North Tyneside, Britain,…

Healthy Returns: Brain implant company Paradromics launches patient registry ahead of human trial

[ad_1] Think a friend or colleague should be getting this newsletter? Share this link with them…

Healthy Returns: Eli Lilly, other drugmakers show off encouraging weight loss drug data

[ad_1] An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York…

Novo Nordisk to build $4.1 billion North Carolina facility to boost output of Wegovy, Ozempic

[ad_1] Novo Nordisk’s new manufacturing facility in Clayton, North Carolina. Courtesy: Novo Nordisk Novo Nordisk on…

Healthy Returns: More U.S. employers are now covering GLP-1s for weight loss

[ad_1] Think a friend or colleague should be getting this newsletter? Share this link with them…

How Eli Lilly is managing soaring demand for GLP-1s, according to outgoing CFO Anat Ashkenazi

[ad_1] A pharmacist holds boxs of Eli Lilly & Co. Mounjaro brand tirzepatide medication arranged at…

Why half of all workers may struggle to get weight-loss drug health insurance coverage

[ad_1] An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York…

How digital health companies are capitalizing on the GLP-1 boom

[ad_1] Patent protection for Wegovy — Novo Nordisk’s blockbuster weight loss drug, which contains the second…

Eli Lilly’s big GLP-1 investment — plus, what we want from 4 portfolio stock earnings

[ad_1] Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at…

AstraZeneca targets $80 billion in total revenue by 2030 in ‘post-Covid era’

[ad_1] The Astrazeneca logo is pictured at the World Artificial Intelligence Conference 2021 in Shanghai, China,…